Properties
Description
Tazemetostat hydrobromide inhibits the enzymes that add methyl groups to histone proteins, altering chromatin structure and gene expression.
Molecular Formula
C34H45BrN4O4
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Tazemetostat hydrobromide can be used to inhibit EZH2 in cancer therapies, particularly lymphomas.